Due to the COVID-19 pandemic, BCBSRI has extended all clinical authorization approvals by Prime Therapeutics as stated below:
Commercial
- Existing clinical prior authorizations for pharmacy drugs with an original expiration date between 31 de março, 2020 and 30 de junho, 2020 have been extended 90 days from the original expiration date to reduce provider and member burden. Restrictions may apply.
- Early refill restrictions are lifted through 30 de junho, 2020. Restrictions may apply.
Medicare
- Existing clinical prior authorizations for pharmacy drugs with an original expiration date between 23 de março, 2020 and 30 de maio, 2020 have been extended 60 days from the original expiration date to reduce provider and member burden. Restrictions may apply.
- Early refill restrictions are lifted through 30 de junho, 2020. Restrictions may apply.